Arcadia Biosciences, Inc. is a producer and marketer of plant-based health and wellness products. The Companyâ€™s product portfolio includes Zola Coconut Water (Zola) and Agronomic Wheat Traits. Zola is a natural, 100% coconut water. Zola is a non-genetically modified organisms (non-GMO) project verified and only contains 60 calories per serving. Zola flavors include original, original with pulp, espresso, lime and pineapple. The recipe with Zola includes smoothies, desserts, cocktails and mocktails, and bowls. It has developed a portfolio of non-GMO specialty wheat traits to offer healthier, nutrient-rich wheat options while providing the same baking quality, taste, and texture as traditional wheat. Its non-GMO Reduced Gluten High Fiber Wheat has fewer allergenic glutens and higher fiber than traditional wheat, while its non-GMO Extended Shelf-Life Wheat extends the shelf life of milled whole wheat flour.

Employees

Sector

Food Processing

More about the company

Quotes

Date	Price	Change	Volume
26-10-07	US$0.2833	-4.93%	242,934
26-10-06	US$0.2980	+3.94%	765,538
26-10-05	US$0.2867	-0.52%	155,095
26-10-02	US$0.2882	+1.48%	209,632
26-10-01	US$0.2840	+1.43%	936,303

Delayed Quote Nasdaq

More quotes

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Arcadia Biosciences, Inc.

Company calendar

Delayed Nasdaq 13:41:10 2026-10-07 EDT			5-day change	1st Jan Change
0.2833 ^USD	-4.93%		+1.18%	-85.69%

08-13	Arcadia Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06-12	Arcadia Biosciences Raises $4 Million in Private Placement	MT

Market Cap	718K 641K 598K 544K 1.02M 69.45M 1.03M 7.19M 2.81M 35.32M 2.7M 2.64M 114M	P/E 2024	-1.15x	P/E 2025	-1.16x
Enterprise Value	-3.85M -3.44M -3.21M -2.91M -5.48M -372M -5.52M -38.52M -15.05M -189M -14.44M -14.12M -608M	EV / Sales 2024	0.79x	EV / Sales 2025	-0.38x
Free-Float	84.13%	Yield 2024 *	-	Yield 2025	-

Markets		Quality
Nasdaq	RKDA	Delayed
CBOE	RKDA	Real-time

08-13	Arcadia Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06-12	Arcadia Biosciences Raises $4 Million in Private Placement	MT
06-11	Arcadia Biosciences, Inc. announced that it has received $3.999613 million in funding	CI
06-10	Arcadia Biosciences, Inc. announced that it expects to receive $3.999613 million in funding	CI
05-14	Arcadia Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-26	Arcadia Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-25	Arcadia Biosciences, Inc. Auditor Raises 'Going Concern' Doubt	CI
02-06	Arcadia Biosciences, Inc. Announces Resignation of Directors, Effective February 4, 2026	CI
01-14	Arcadia Biosciences enters inducement offer letter agreements with certain investors - SEC filing	RE
12-26	Health Care Stocks Recover In Late Trade -- Health Care Roundup	DJ
12-26	Arcadia Biosciences, Roosevelt Resources Terminate Business Combination Agreement	MT
12-26	Arcadia Biosciences receives termination notice of the proposed business combination with Roosevelt Resources	RE
11-07	Arcadia Biosciences Q3 revenue falls	RE

Arcadia Biosciences, Inc. Stock

Stocks

RKDA

US0390143032

Food Processing

Valuation: Arcadia Biosciences, Inc.

Chart: Arcadia Biosciences, Inc.

Latest news: Arcadia Biosciences, Inc.

Analysts' recommendations: Arcadia Biosciences, Inc.

Press Releases: Arcadia Biosciences, Inc.

News in other languages: Arcadia Biosciences, Inc.

Quotes and Performance

Price Extremes

Managers and Directors: Arcadia Biosciences, Inc.

Latest insider transactions

Vegan & Vegetarian Food Manufacturing

Financials

Company Profile

Quotes

Quarterly revenue - Rate of surprise

23-06-05	HC Wainwright Adjusts Price Target on Arcadia Biosciences to $15 From $18, Keeps Buy Rating	MT
23-03-31	Lake Street Adjusts Arcadia Biosciences Price Target to $20 From $80, Maintains Buy Rating	MT
22-08-26	HC Wainwright Adjusts Price Target on Arcadia Biosciences to $3 From $4, Reiterates Buy Rating	MT
22-01-03	HC Wainwright Cuts Price Target on Arcadia Biosciences to $6 From $7, Maintains Buy Rating	MT
21-06-01	Arcadia Biosciences : HC Wainwright Adjusts Arcadia Biosciences' Price Target to $7 From $6, Maintains Buy Rating	MT

08-13	Arcadia Biosciences : Announces Second Quarter and First Half 2026 Financial Results and Business Highlights	PU
08-13	Arcadia Biosciences: Q2 Earnings Snapshot	AQ
08-13	Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2026 Financial Results and Business Highlights	GL
06-12	Arcadia Biosciences : Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules	PU
06-12	Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules	GL

21-02-08	Planète Bourse : La revue de presse du lundi 8 févier 2021
20-12-21	Planète Bourse : La revue de presse du lundi 21 décembre 2020
20-12-01	Planète Bourse - La revue de presse du mardi 1er décembre 2020

1 day	-6.38%
1 week	+1.18%
Current month	+1.18%
1 month	-39.74%
3 months	-59.72%
6 months	-78.37%
Current year	-85.69%

1 week	0.26	0.31
1 month	0.22	0.68
Current year	0.22	2.75
1 year	0.22	6.71
3 years	0.22	10.31
5 years	0.22	106.4
10 years	0.22	2,662.4

Director	Title	Age	Since
Kevin Comcowich CHM	Chairman	57	2017-11-21
Gregory Waller BRD	Director/Board Member	76	2017-06-12
Amy Yoder BRD	Director/Board Member	58	2017-08-09

Date	Insider	Type	Main position	Quantity	% Market Cap.
9/10/26	Amy Yoder	Free	Director	10,000	0.4151%
9/10/26	Kevin Comcowich	Free	Chairman	23,000	0.9547%
9/10/26	Lilian Murray	Free	Director	10,000	0.4151%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ARCADIA BIOSCIENCES, INC.	-4.93%	+1.18%	-91.62%	-90.74%	718K
NESTLÉ S.A.	+0.48%	-0.61%	+1.44%	-25.48%	233B
MONDELEZ INTERNATIONAL, INC.	-0.19%	+2.81%	-5.04%	-6.78%	76.09B
DANONE	-0.07%	+0.14%	-18.52%	+11.52%	42.63B
ARCHER-DANIELS-MIDLAND COMPANY	-1.23%	+2.19%	+28.99%	+9.77%	39.62B
THE HERSHEY COMPANY	-0.13%	+1.76%	-17.49%	-18.05%	32.31B
AJINOMOTO CO., INC.	-0.48%	+4.60%	+25.20%	+80.39%	32.44B
FOSHAN HAITIAN FLAVOURING AND FOOD COMPANY LTD.	+0.79%	+0.79%	-14.86%	-12.69%	28.38B
NESTLÉ INDIA LIMITED	-1.07%	+0.69%	+12.30%	+15.50%	26.71B
KRAFT HEINZ	-0.48%	-3.39%	-13.65%	-32.44%	26.12B
Average	-0.87%	+0.45%	-9.33%	-6.90%	53.72B
Weighted average by Cap.	+0.01%	-0.44%	+0.21%	-8.08%

	2024	2025
Net sales	5.04M 4.51M 4.21M 3.82M 7.19M 488M 7.25M 50.54M 19.74M 248M 18.94M 18.53M 798M	4.86M 4.34M 4.05M 3.68M 6.93M 470M 6.98M 48.66M 19.01M 239M 18.24M 17.84M 768M
Net income	-7.04M -6.29M -5.87M -5.33M -10.04M -681M -10.11M -70.5M -27.54M -346M -26.42M -25.85M -1.11B	-2.34M -2.09M -1.95M -1.77M -3.34M -226M -3.36M -23.43M -9.15M -115M -8.78M -8.59M -370M
Net Debt	-4.09M -3.65M -3.41M -3.09M -5.83M -395M -5.87M -40.94M -15.99M -201M -15.34M -15.01M -646M	-4.56M -4.08M -3.8M -3.46M -6.51M -441M -6.56M -45.71M -17.86M -224M -17.13M -16.76M -722M